Gyre Therapeutics, Inc. - PE Ratio

The PE Ratio as of September 2026 (TTM) for Gyre Therapeutics, Inc. (GYRE) is 102.57

According to Gyre Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 102.57. This represents a change of -626.57% compared to the average of -19.48 of the last 4 quarters.

Gyre Therapeutics, Inc. (GYRE) Historical PE Ratio (quarterly & annually)

How has GYRE PE Ratio performed in the past?

The mean historical PE Ratio of Gyre Therapeutics, Inc. over the last ten years is 31.99. The current 102.57 PE Ratio has changed 31.96% with respect to the historical average. Over the past ten years (40 quarters), GYRE's PE Ratio was at its highest in in the September 2024 quarter at 239.31. The PE Ratio was at its lowest in in the December 2024 quarter at -2520.83.

Gyre Therapeutics, Inc. (GYRE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Gyre Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gyre Therapeutics, Inc. (GYRE) Average PE Ratio

How has GYRE PE Ratio performed in the past?

The current PE Ratio of Gyre Therapeutics, Inc. (GYRE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Gyre Therapeutics, Inc. (GYRE) PE Ratio vs. Peers

How is GYRE’s PE Ratio compared to its peers?

Gyre Therapeutics, Inc.’s PE Ratio is greater than Anavex Life Sciences Corp. (-9.22), greater than Erasca, Inc. (-16.15), greater than CytomX Therapeutics, Inc. (-6.27), greater than MBX Biosciences, Inc. Common Stock (-26.62), greater than MoonLake Immunotherapeutics (-3.21), greater than Astria Therapeutics, Inc. (-7.40), greater than Keros Therapeutics, Inc. (-3.07), greater than MeiraGTx Holdings plc (17.17), greater than Iovance Biotherapeutics, Inc. (-14.31), greater than ArriVent BioPharma, Inc. (-7.71),

Build a custom stock screener for Gyre Therapeutics, Inc. (GYRE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gyre Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gyre Therapeutics, Inc. (GYRE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gyre Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.